AXIL (AXIL Brands Inc) Market Value to Book Value Ratio

Official company branding of reviveprocare.com (AXIL)

This daily price chart for AXIL Brands, Inc. (AXIL) reflects the company's transition to eco-friendly cardboard packaging as a replacement for plastic. The business relies on the expansion of omnichannel retail and the demand for hearing protection, with the key metric standing at 2.80. Growth prospects are driven by the ownership of Revive Procare and the development of anti-aging skin formulas adapted for various climatic zones.

AXIL reviveprocare.com: Market Value to Book Value in the range 02/21/2024 - 10/27/2026

Financial and market metric breakdowns for AXIL Brands, Inc. (AXIL)

- price and consensus price forecast:
Price Chart reviveprocare.com|AXIL - Price Target Chart
- market capitalization data:
Market Value AXIL|AXIL - Full Business Value
- book capitalization data:
Book Value per Share AXIL Brands|AXIL - Accounting Value of Company|Market Capitalization to Book Value Ratio reviveprocare.com|AXIL - Company Total Assets
- debt and liquidity data:
Debt to Equity AXIL Brands, Inc.|AXIL - Long-Term Debt to Capital Coefficient|Short-Term Debt to Equity reviveprocare.com|AXIL - Company Total Debt|Debts to Book Capitalization AXIL
Initial company analysis:AXIL Brands Inc - AXIL
Original product of reviveprocare.com

The reliability of an equity asset is determined by comparing its market value to the actual volume of net assets. This ratio measures the premium over book value, showing how much an investor pays for every dollar of AXIL Brands, Inc. (AXIL) equity. The transition to cardboard packaging optimizes costs, impacting the value of inventory. By analyzing this chart of the market-to-book value ratio, one can assess the degree to which the shares are overbought. High values signal inflated market expectations.

Main competitors

Krystal Biotech, Inc. (KRYS) - Market Value to Book Value Ratio|APGE (apogeetherapeutics.com) - Market Value to Book Value Ratio|Market Value to Book Value Ratio Arcutis Biotherapeutics, Inc. ARQT|Market Capitalization to Net Assets Vericel Corp|Oruka Corp (ORKA) - Market Capitalization to Book Value Ratio|Market Value to Book Value sanaramedtech.com (SMTI)|Market Capitalization to Book Value Ratio DBVT (DBV Technologies)|Solesence Beauty - Market Capitalization to Book Value Ratio|Market Value to Book Value Ratio Journey Medical Corp. (DERM)|FBRX: Market Value to Book Value|EMPG (Empro) - Market Value to Book Value Ratio|Sol-Gel Technologies, Ltd. (SLGL) - Market Cap to Net Assets Ratio|MDCX (Medicus Pharma Ltd.) - Market Capitalization to Book Value Ratio|Market Capitalization to Book Value Ratio Verrica (VRCA)|Hoth Therapeutics, Inc. (HOTH) - Market Cap to Net Assets Ratio|Market Value to Book Value BFRI (biofrontera-us.com)|Market Value to Book Value Ratio VYNE|Sonoma Pharmaceuticals Inc. - Market Capitalization to Book Value|Quoin Pharma - Market Value to Book Value Ratio|AZTR - Market Capitalization to Book Value Ratio|Dermata Therapeutics, Inc. - Market Capitalization to Book Value Ratio|ELAB (Elevai Labs Inc) - Market Capitalization to Book Value|Market Value to Book Value Ratio Revance Therapeutics, Inc (RVNC)